Skip to main content

B vitamins slow brain atrophy in people with memory problems

B vitamins slow brain atrophy in people with memory problems


Image result for vitamins

Daily tablets of certain B vitamins can halve the rate of brain shrinkage in elderly people who suffer from mild memory problems, an Oxford University study has shown.take vitamins today
The two-year randomised clinical trial is the largest to study the effect of B vitamins on mild cognitive impairment, and one of the first disease-modifying trials in the Alzheimer's field to show positive results in people.
Around 1 in 6 elderly people over the age of 70 has mild cognitive impairment, experiencing problems with memory, language, or other mental functions, but not to a degree that interferes with daily life. Around half of people with mild cognitive impairment go on to develop dementia -- mainly Alzheimer's disease -- within five years of diagnosis.
Certain B vitamins -- folic acid, vitamin B6 and vitamin B12 -- are known to control levels of the amino acid homocysteine in the blood, and high levels of homocysteine are associated with an increased risk of Alzheimer's.
So the Oxford team set out to see whether supplements of the B vitamins that lower homocysteine could slow the higher rate of brain shrinkage, or atrophy, observed in mild cognitive impairment or Alzheimer's.
The study followed 168 volunteers aged 70 or over with mild memory problems, half of whom took high dose B vitamin tablets for two years and the other half a placebo tablet. The researchers assessed disease progression in this group by using MRI scans to measure the brain atrophy rate over a two-year period. The findings are published in the journal PLoS ONE.
The team found that on average the brains of those taking the folic acid, vitamin B6 and B12 treatment shrank at a rate of 0.76% a year, while those in the placebo group had a mean brain shrinkage rate of 1.08%. People with the highest levels of homocysteine benefited most, showing atrophy rates on treatment that were half of those on placebo.
Along with rate of brain shrinkage, the team from the Oxford Project to Investigate Memory and Ageing (OPTIMA) also monitored cognitive test scores, revealing that those with the slowest rate of shrinkage scored more strongly.
The team suggests that, since the rate of brain atrophy is known to be more rapid in those with mild cognitive impairment who go on to develop Alzheimer's, it is possible that the vitamin treatment could slow down the development of the disease. Clinical trials to test this should now be carried out, they add.
'It is our hope that this simple and safe treatment will delay the development of Alzheimer's disease in many people who suffer from mild memory problems,' said Professor David Smith of the Department of Pharmacology at Oxford University, a co-leader of the trial. 'Today there are about 1.5 million elderly in UK, 5 million in USA and 14 million in Europe with such memory problems.
'These are immensely promising results but we do need to do more trials to conclude whether these particular B vitamins can slow or prevent development of Alzheimer's. So I wouldn't yet recommend that anyone getting a bit older and beginning to be worried about memory lapses should rush out and buy vitamin B supplements without seeing a doctor,' he said.
Rebecca Wood, Chief Executive of the Alzheimer's Research Trust, which co-funded the study, said: 'These are very important results, with B vitamins now showing a prospect of protecting some people from Alzheimer's in old age. The strong findings must inspire an expanded trial to follow people expected to develop Alzheimer's, and we hope for further success.
'We desperately need to support research into dementia, to help avoid the massive increases of people living with the condition as the population ages. Research is the only answer to what remains the greatest medical challenge of our time.'
Professor Chris Kennard, chair of the Medical Research Council's Neurosciences and Mental Health Board which co-funded the study, said: 'This MRC-funded trial brings us a step closer to unravelling the complex neurobiology of ageing and cognitive decline, which holds the key to the development of future treatments for conditions like Alzheimer's disease. The findings are very encouraging and we look forward to further research that is needed in order to test whether B vitamins can be recommended as a suitable treatment.'take vitamins today
Story Source:
Materials provided by University of Oxford. Note: Content may be edited for style and length.
Journal Reference:
  1. A. David Smith, Stephen M. Smith, Celeste A. de Jager, Philippa Whitbread, Carole Johnston, Grzegorz Agacinski, Abderrahim Oulhaj, Kevin M. Bradley, Robin Jacoby, Helga Refsum, Ashley I. Bush. Homocysteine-Lowering by B Vitamins Slows the Rate of Accelerated Brain Atrophy in Mild Cognitive Impairment: A Randomized Controlled Trial. PLoS ONE, 2010; 5 (9): e12244 DOI: 10.1371/journal.pone.0012244
Labels:

Comments

Post a Comment

Popular posts from this blog

Essential Minerals

Minerals: Functions and Sources The body needs many minerals; these are called essential minerals . Essential minerals are sometimes divided up into major minerals (macrominerals) and trace minerals (microminerals).  A balanced diet usually provides all of the essential minerals. The two tables below list minerals, what they do in the body (their functions), and their sources. Major minerals Mineral Function Sources Sodium Needed for proper fluid balance, nerve transmission, and muscle contraction Table salt, soy sauce; large amounts in processed foods; small amounts in milk, breads, vegetables, and unprocessed meats Chloride Needed for proper fluid balance, stomach acid Table salt, soy sauce; large amounts in processed foods; small amounts in milk, meats, breads, and vegetables Potassium Needed for proper fluid balance, nerve transmission, and muscle contraction Meats, milk, fresh fruits and vegetables, whole grains, legumes Calciu...
5 comments
Read more

Vitamin C Can Reduce High Blood Pressure, Study Finds

Vitamin C Can Reduce High Blood Pressure, Study Finds CORVALLIS, Ore. - Researchers have discovered that a 500 milligram daily supplement of vitamin C can significantly reduce high blood pressure in hypertensive patients. The study, published this month in the medical journal Lancet, was done by scientists at the Boston University School of Medicine and the Linus Pauling Institute at Oregon State University. It was supported by the National Heart, Lung and Blood Institute of the National Institutes of Health. "Hypertension is a serious health problem in much of the world," said Balz Frei, professor and director of the Linus Pauling Institute, and a co-author of the research along with principal investigator Dr. Joseph Vita at Boston University. "It's a key risk factor in heart disease and strokes." "We believe this is a significant finding that may be of considerable value to patients who have moderately elevated blood pressure," Frei s...
Post a Comment
Read more

Zinc can halt the growth of cancer cells, study says

Zinc can halt the growth of cancer cells, study says Zinc supplements can significantly inhibit the proliferation of esophageal cancer cells, according to a new study co-authored by a University of Texas at Arlington researcher. Previous studies had shown that zinc is essential for maintaining human health and protects the esophagus from cancer. However, it has never been fully understood why zinc has the ability to prevent cancer in the esophagus. In this study, a team led by Zui Pan, an associate professor of nursing at UTA's College of Nursing and Health Innovation and a noted esophageal cancer researcher, discovered that zinc selectively halts the growth of cancer cells but not normal esophageal epithelial cells. The finding was published this month in  The FASEB Journal , the official journal of the Federation of American Societies for Experimental Biology. Esophageal cancer is the sixth leading cause of human cancer deaths around the world, according to the Nation...
Post a Comment
Read more